State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
70.02
+0.22 (0.32%)
Aug 5, 2026, 4:00 PM EDT - Market closed
XPH Holdings Information
XPH is an equity ETF with a total of 66 individual holdings. The top holdings are Crinetics Pharmaceuticals stock at 3.59%, MBX Biosciences at 3.16%, Definium Therapeutics at 2.82%, AtaiBeckley at 2.80%, and Amylyx Pharmaceuticals at 2.27%.
Total Holdings
66
Top 10 Percentage
25.35%
Asset Class
Equity
ETF Category
Health
Assets
501.99M
PE Ratio
14.96
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.59% |
| 2 | MBX | MBX Biosciences, Inc. | 3.16% |
| 3 | DFTX | Definium Therapeutics, Inc. | 2.82% |
| 4 | ATAI | AtaiBeckley Inc. | 2.80% |
| 5 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.27% |
| 6 | CORT | Corcept Therapeutics Incorporated | 2.23% |
| 7 | NUVB | Nuvation Bio Inc. | 2.16% |
| 8 | ELVN | Enliven Therapeutics, Inc. | 2.15% |
| 9 | ALMS | Alumis Inc. | 2.13% |
| 10 | TRVI | Trevi Therapeutics, Inc. | 2.03% |
| 11 | LQDA | Liquidia Corporation | 1.96% |
| 12 | NKTR | Nektar Therapeutics | 1.86% |
| 13 | EWTX | Edgewise Therapeutics, Inc. | 1.84% |
| 14 | AMRX | Amneal Pharmaceuticals, Inc. | 1.78% |
| 15 | LGND | Ligand Pharmaceuticals Incorporated | 1.76% |
| 16 | OMER | Omeros Corporation | 1.73% |
| 17 | BMY | Bristol-Myers Squibb Company | 1.72% |
| 18 | ETON | Eton Pharmaceuticals, Inc. | 1.71% |
| 19 | ELAN | Elanco Animal Health Incorporated | 1.71% |
| 20 | PCRX | Pacira BioSciences, Inc. | 1.70% |
| 21 | VTRS | Viatris Inc. | 1.66% |
| 22 | MANE | Veradermics, Incorporated | 1.66% |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 1.66% |
| 24 | MAZE | Maze Therapeutics, Inc. | 1.66% |
| 25 | MRK | Merck & Co., Inc. | 1.61% |
As of Jul 30, 2026